Prenuvo

Prenuvo is a leader in proactive whole-body MRI screening, offering a non-invasive and radiation-free way to detect early signs of cancer, aneurysms, and other diseases. Using advanced AI-powered technology, Prenuvo provides comprehensive insights into a patient's health by assessing the body holistically in under 60 minutes.

Funding Round: Series B

Funding Amount: $120M

Date: 13-Feb-2025

Investors: Forerunner Ventures, Left Lane Capital, Felicis

Markets: Healthtech, Oncology, Artificial Intelligence & Machine Learning

HQ: Los Angeles, California, United States

Founded: 2018

Website: https://prenuvo.com/

LinkedIn: https://www.linkedin.com/company/prenuvo

Twitter: https://twitter.com/prenuvo

Instagram:

Facebook: https://www.facebook.com/prenuvo